Sechenov School
Home › Pathology › Tumor Morphogenesis and Progression

Tumor Morphogenesis and Progression

Carcinoma in situ

For medical students2 min readUpdated 2026-10-10

Tumor morphogenesis refers to the origin and staged development of a neoplasm, while progression reflects its continuous growth and qualitative changes. The material basis of malignancy is the active synthesis of oncoproteins and growth factors, which ultimately determines the degree of cellular atypia and helps predict patient survival.

Basis of transformationSomatic cell mutations play a decisive role
Duration in situThe non-invasive stage can last for 10 years or more
Stem cellsAccount for less than 2% of the population in breast carcinoma
Avascular nutritionIn early stages, the tumor is nourished diffusely from adjacent tissues

Basics of Morphogenesis and Theories of Carcinogenesis

In studying morphogenesis, pathology addresses four key questions: the source of cells (whether the tumor arises de novo or in stages), the nature of the developmental stages, clonality (monoclonal or polyclonal origin), and how the neoplasm interacts with the host organism.

There are two main theories of cellular transformation:

  1. Saltatory transformation theory. Proposes tumor development without preceding tissue changes (a single-step model). This is supported by data from experimental viral carcinogenesis.
  2. Staged transformation theory. Developed by L.M. Shabad and supported by most experimental models. It is based on the accumulation of mutations in somatic cells.

Cancer stem (initiating) cells play a critical role in tumor origin by sustaining the growth of the tumor mass. Their proportion in the population is extremely small (e.g., 0.1–1.0% in acute myeloid leukemia); however, their survival after treatment leads to recurrence. Note: the existence of such cells has not been proven for all tumor types.

Stages of Tumor Development

Historically, L.M. Shabad distinguished four stages: focal hyperplasia, diffuse hyperplasia, benign tumor, and malignant tumor (the first three considered preneoplastic processes). Currently, the classification of morphogenetic stages has been refined:

Features of Non-Invasive Cancer (Carcinoma in situ)

The progression of dysplasia under the influence of additional factors leads to genetic rearrangements and malignant transformation. A malignant cell arises, forming a clone.

At the carcinoma in situ stage (intraepithelial neoplasia), the tumor grows "within itself." The basement membrane is intact, and there are no native blood vessels or stroma. Nutrition is provided exclusively through the diffusion of substances from the tissue fluid of adjacent normal tissues.

Why is there no angiogenesis at this stage? There are two hypotheses. The first attributes this to the small tumor mass (lack of stimulating factors). The second, more probable hypothesis, explains this by the absence of specific genetic rearrangements required to trigger invasive growth.

Invasion and the Genetic Model of Progression

Upon transitioning to the invasive tumor stage, infiltrative growth begins. The neoplasm develops a vascular network, forms a stroma, and clear boundaries with healthy tissue disappear due to cellular infiltration. The pathogenesis of invasion proceeds in 3 phases and is tightly controlled by genetics.

Colorectal carcinogenesis serves as a classic model for the staged accumulation of mutations:

Morphological StageGenetic AlterationsLocalization
Hyperplastic epitheliumMutations or loss of APC, MCCChromosome 5q
Early adenomaImpaired DNA methylation—
Late adenomaK-ras mutation, loss of DCCChromosomes 12q, 18q
Carcinomap53 mutation and lossChromosome 17q
Metastatic carcinomaAccumulation of mutationsDeletion of 17q

Mnemonic

To remember the modern stages of morphogenesis, use the phrase "Pre-Invasive Invasion Metastases": Preneoplasia, Non-invasive stage (in situ), Invasive growth, Metastasis.

Frequently asked questions

What are the three phases in the pathogenesis of tumor invasive growth?

The pathogenesis of tumor invasive growth involves three sequential phases.

  • First phase (Epithelial-mesenchymal transition) — weakening of intercellular junctions, increased expression of mobility molecules and integrins.
  • Second phase (Matrix degradation) — secretion of proteolytic enzymes by the tumor cell and degradation of the extracellular matrix to clear a path for invasion.
  • Third phase (Migration) — accumulation of breakdown products of fibronectin and laminin, which act as chemoattractants, drawing tumor cells toward the degradation zone.
What nuclear and cellular morphological changes indicate cellular atypia?

Cellular atypia is characterized by marked alterations in cell and nuclear structure.

  • Cellular changes (pleomorphism) — pronounced variability in shape and size, presence of giant, small primitive, and multinucleated cells.
  • Nuclear changes — polyploidy, hyperchromasia (dark staining), increased nuclear-cytoplasmic ratio, pleomorphism, irregular contours, and prominent nucleoli.

Cellular atypia also includes altered mitotic activity with pathological mitotic figures.

What are the main differences between a benign and a malignant tumor?

The main differences lie in the type of atypia, degree of cell differentiation, and pattern of growth.

FeatureBenign TumorMalignant Tumor
AtypiaOnly tissue atypia is characteristicBoth tissue and cellular atypia are present
CellsComposed of mature, differentiated elementsCells and nuclei exhibit significant pleomorphism
MitosesExtremely rarePathological mitotic figures present
Growth patternExpansive (compresses tissues, forms a capsule)Infiltrative (invades and destroys surrounding structures)
What are the main pathways of malignant tumor metastasis?

The primary mechanisms for the spread of tumor cells from the primary site to other organs and tissues are:

  • Lymphatic — spread via lymphatic vessels (retrograde metastasis against lymph flow is possible).
  • Hematogenous — spread via blood vessels.
  • Perineural — spread along nerve trunks.
  • Implantation — contact spread along serous cavities.
Which growth factors stimulate angiogenesis during the transition of a tumor to the invasive stage?

Tumor angiogenesis is driven by angiogenic growth factors and extracellular matrix composition. Angiogenic factors include:

  • Fibroblast growth factors, including Volkmann's factor, produced by malignant tumor cells to stimulate vascular wall proliferation and vessel growth.
  • Angiogenin.
  • Angiopoietins.

Extracellular matrix components, including laminin, fibronectin, and type IV collagen, are also important. Neoplasm growth directly depends on the development of the vascular network; tumor vessels are often defective and predominantly capillary-like.

Why can a tumor recur after successful treatment?

If therapy destroys the bulk of the cells but spares the cancer stem (initiating) cells, they survive and re-initiate tumor growth.

How does cancer feed at the carcinoma in situ stage if it lacks blood vessels?

At this stage, the tumor nodule receives nutrients via diffusion from the tissue fluid of neighboring healthy structures.

What is the main morphological sign of preneoplastic dysplasia?

The key criterion is the appearance of signs of cellular atypia in the parenchymal elements of the tissue.

Go deeper

More topics in Pathology

Renal Involvement in Systemic DiseasesInterstitial PneumoniaGastric Precancerous LesionsDrug-Induced HepatitisAcute Viral Respiratory InfectionsHodgkin LymphomaPathomorphosis: Definition, Types and Clinical ExamplesPediatric Genetic and Metabolic DisordersSialadenitis and Salivary Gland TumorsDisseminated Intravascular Coagulation (DIC)Parenchymal Carbohydrate DystrophiesSpecific Types of Cell DeathPathology →